Literature DB >> 9453969

[Non-Hodgkin lymphomas].

F Weissinger1, H H Kreipe, M Wilhelm.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9453969     DOI： 10.1007/s001080050125

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  1 in total

1.  Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).

Authors:  M Herold; A Schulze; D Niederwieser; A Franke; H J Fricke; P Richter; M Freund; B Ismer; K Dachselt; C Boewer; V Schirmer; J Weniger; R Pasold; C Winkelmann; C Klinkenstein; M Schulze; H Arzberger; K Bremer; S Hahnfeld; A Schwarzer; C Müller; Chr Müller
Journal:  J Cancer Res Clin Oncol       Date:  2005-08-09       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.